Solid dispersions, Part II: New strategies in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs

Expert Opinion on Drug Delivery

Volumn 8, Issue 12, 2011, Pages 1663-1680

  Bikiaris, Dimitrios N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Electrospinning; Melt mixing; Microwave irradiation; Nanocomposites; Poorly water soluble drugs; Solid dispersions; Solubility enhancement; Supercritical

Indexed keywords

BEZAFIBRATE; BICALUTAMIDE; CAPTOPRIL; DRUG; DRUG CARRIER; EUDRAGIT; FELODIPINE; FERULIC ACID; GLICLAZIDE; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; ITRACONAZOLE; KETOPROFEN; KINETISOL; MACROGOL; NANOCOMPOSITE; NANOFIBER; NANOPARTICLE; NEVIRAPINE; NIMESULIDE; NIMODIPINE; OXEGLITAZAR; PARACETAMOL; POVIDONE; PRAVASTATIN; RITONAVIR; SPIRONOLACTONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VALDECOXIB;

CONDUCTANCE; CRYSTAL; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MIXTURE; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; ELASTICITY; ELECTRIC POTENTIAL; ELECTROSPINNING; ENVIRONMENTAL IMPACT; EVAPORATION; GLASS TRANSITION TEMPERATURE; HIGH TEMPERATURE PROCEDURES; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; HYDROSTATIC PRESSURE; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; LOW TEMPERATURE PROCEDURES; MICROWAVE IRRADIATION; MISCIBILITY; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; POROSITY; PRECIPITATION; REVIEW; SOLID; SURFACE TENSION; TEMPERATURE; VISCOSITY; WATERCRESS; WETTABILITY;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; MICROWAVES; NANOCOMPOSITES; NANOPARTICLES; PARTICLE SIZE; POLYMERS; SOLUBILITY; WATER;

EID: 80054829203     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.618182     Document Type: Review

References (96)

1. Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;8:413-20
2. Lipinski C. Poor aqueous solubility-an industry wide problem in drug delivery. Am Pharm Rev 2002;5:82-5
3. Kesisoglu F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631-44 (Pubitemid 47285408)
4. Cho E, Cho W, Cha KH, et al. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives. Int J Pharm 2010;396:91-8
5. Hu J, Johnston KP, Williams RO III. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 2004;30:233-45 (Pubitemid 38451748)
6. Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 2006;62:3-16 (Pubitemid 41736019)
7. Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008;364:64-75
8. Dong Y, Ng WK, Hu J, et al. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs. Int J Pharm 2010;386:256-61
9. Sethia S, Squillante E. Solid dispersions: revival with greater possibilities and applications in oral drug delivery. Crit Rev Ther Drug Carrier Syst 2003;20:215-47 (Pubitemid 37237280)
10. Kaushal AM, Gupta P, Bansal AK. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst 2004;21:133-93 (Pubitemid 41647581)
11. Karavas E, Georgarakis E, Sigalas MP, et al. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. Eur J Pharm Biopharm 2007;66:334-47 (Pubitemid 46778978)
12. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068-75 (Pubitemid 350186132)
13. Mc Ginity JW, Zhang F, Koleng JJ, et al. Hot-melt extrusion as a pharmaceutical process. Am Pharma Rev 2001;4:25-37
14. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107-17 (Pubitemid 34919382)
15. Liu H, Wang P, Zhang X, et al. Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions. Int J Pharm 2010;383:161-9
16. Hughey JR, Di Nunzio JC, Bennett RC, et al. Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: A comparative study of hot melt extrusion and Kineti Sol® Dispersing. AAPS Pharm Sci Tech 2010;11:760-74,2010 17.
17. Repka MA, Majumdar S, Battu SK, et al. Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv 2008;5:1357-76
18. Tho I, Liepold B, Rosenberg J, et al. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci 2010;40:25-32
19. Andrews GP, Abudiak OA, Jones DS. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J Pharm Sci 2010;99:1322-35
20. Miller DA, Mc Conville JT, Yang W, et al. Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci 2007;96:361-76 (Pubitemid 46363567)
21. Albers J, Alles R, Matthée K, et al. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur J Pharm Biopharm 2009;71:387-94
22. Yang M, Wang P, Huang CY, et al. Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing. Int J Pharm 2010;395:53-61
23. Docoslis A, Huszarik KL, Papageorgiou GZ, et al. Characterization of the distribution, polymorphism, and stability of nimodipine in its solid dispersions in polyethylene glycol by micro-Raman spectroscopy and powder X-Ray diffraction. AAPS J 2007;9:E361-70 24.
24. Papageorgiou GZ, Bikiaris D, Karavas E, et al. Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. AAPS J 2006;8:E623-31 (Pubitemid 44644163)
25. Jijun F, Lili Z, Tingting G, et al. Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Techn 2010;204:214-21
26. Shibata Y, Fujii M, Sugamura Y, et al. The preparation of a solid dispersion powder of indomethacin with crospovidone using a twin-screw extruder or kneader. Int J Pharm 2009;365:53-60
27. Shah J, Vasanti S, Anroop B, et al. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: preparation and in vitro evaluation. J Incl Phenom Macrocycl Chem 2009;63:69-75
28. Bley H, Fussnegger B, Bodmeier R Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm 2010;390:165-73
29. Schilling SU, Shah NH, Malick AW, et al. Citric acid as a solid-state plasticizer for Eudragit RS PO. J Pharm Pharmacol 2007;59:1493-500 (Pubitemid 350057451)
30. Lakshman JP, Cao Y, Kowalski J, et al. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm 2009;5:994-1002
31. Di Nunzio JC, Brough C, Miller DA, et al. Fusion processing of itraconazole ® solid dispersions by Kineti Sol dispersing: a comparative study to hot melt extrusion. J Pharm Sci 2009;99:1239-53
32. Di Nunzio JC, Brough C, Hughey JR, et al. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing. Eur J Pharm Biopharm 2010;74:340-51
33. Yeo SD, Kiran E. Formation ofpolymer particles with supercritical fluids: a review. J Supercr Fluids 2005;34:287-308 (Pubitemid 40584247)
34. Vemavarapu C, Mollan MJ, Needham TE. Coprecipitation of pharmaceutical actives and their structurally related additives by the RESS process. Powder Techn 2009;189:444-53
35. Lim RTY, Ng WK, Tan RBH. Amorphization of pharmaceutical compound by co-precipitation using supercritical anti-solvent (SAS) process (Part I). J Supercr Fluids 2010;53:179-84
36. Galia A, Scialdone O, Filardo G, et al. A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide. Int J Pharm 2009;377:60-9
37. De Sousa ARS, Silva R, Tay FH, et al. Solubility enhancement of trans-chalcone using lipid carriers and supercritical CO2 processing. J Supercr Fluids 2009;48:120-5
38. Wu K, Li J, Wang W, et al. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent. J Pharm Sci 2009;98:2422-31
39. Turk M. Manufacture of submicron drug particles with enhanced dissolution behavior by rapid expansion processes. J Supercr Fluids 2009;47:537-45
40. Sonoda R, Hara Y, Iwasaki T, et al. Improvement of dissolution property of poorly water-soluble drug by supercritical freeze granulation. Chem Pharm Bull 2009;57:1040-4
41. Varshosaz J, Hassanzadeh F, Mahmoudzadeh M, et al. Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercritical fluid technology. Powder Techn 2009;189:97-102
42. Türk M, Lietzow R. Formation and stabilization of submicron particles via rapid expansion processes. J Supercr Fluids 2008;38:346-55
43. Hezave AZ, Esmaeilzadeh F. Investigation of the rapid expansion of supercritical solution parameters effects on size and morphology of cephalexin particles. J Aerosol Sci 2010;41:1090-112
44. Turk M, Bolten D. Formation of submicron poorly water-soluble drugs by rapid expansion of supercritical solution (RESS): results for naproxen. J Supercr Fluids 2010;55:778-85
45. Kim MS, Kim JS, Hwang SJ. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives. Chem Pharm Bul 2010;58:230-3
46. Kale K, Hapgood K, Stewart P. Drug agglomeration and dissolution-what is the influence of powder mixing. Eur J Pharm Sci 2009;72:156-64
47. Sanganwar GP, Sathigari S, Babu RJ, et al. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement. Eur J Pharm Sci 2010;39:164-74
48. Badens E, Majerik V, Horv Oíth G, et al. Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologies. Int J Pharm 2009;377:25-34
49. Brion M, Jaspart S, Perrone L, et al. The supercritical micronization of solid dispersions by Particles from Gas Saturated Solutions using experimental design. J Supercr Fluids 2009;51:50-6
50. Kluge J, Fusaro F, Muhrer G, et al. Rational design of drug-polymer co-formulations by CO2 anti-solvent precipitation. J Supercr Fluids 2009;48:176-82
51. Yu DG, Zhu LM, White K, et al. Electrospun nanofiber based drug delivery systems. Health 2009;1:67-75
52. Ignatious F, Sun L, Lee CP, et al. Electrospun nanofibers in oral drug delivery. Pharm Res 2010;27:576-688
53. Yu DG, Gao LD, White K, et al. Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug. Pharm Res 2010;27:2466-77
54. Natu MV, De Sousa HC, Gil MH. Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers. Int J Pharm 2010;397:50-8
55. Yu DG, Branford-White C, Shen XX, et al. Solid dispersions of ketoprofen in drug-loaded electrospun nanofibers. J Disper Sci Technol 2010;31:902-8
56. Nagy ZK, Nyul K, Wagner I, et al. Electrospun water soluble polymer mat for ultrafast release of donepezil HCl e XPRESS. Polym Lett 2010;4:763-72
57. Yu DG, Shen XX, Branford-White C, et al. Oral fast-dissolving drug delivery membranes prepared from electrospun PVP ultrafine fibers. Nanotechnology 2009;20:055104
58. Yu DG, Yang JM, Branford-White C, et al. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. Int J Pharm 2010;400:158-64
59. Yu DG, Branford-White C, White K, et al. Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen. AAPS Pharm Sci Tech 2010;11:809-17
60. Chen HM, Yu DG. An elevated temperature electrospinning process for preparing acyclovir-loaded PAN ultrafine fibers. J Mater Process Technol 2010;210:1551-5
61. Lehmann H, La Vecchia L. Evaluation of microwave reactors for prep-scale synthesis in a kilolab. JALA 2005;10:412-17 (Pubitemid 43055618)
62. Mavandadi F, Pilotti A. The impact of microwave-assisted organic synthesis in drug discovery. Drug Discov Today 2006;11:165-74 (Pubitemid 43375968)
63. Kappe CO, Dallinger D. The impact of microwave synthesis on drug discovery. Nat Rev 2005;5:51-63
64. Wong TW. Use ofmicrowave in processing of drug delivery systems. Curr Drug Deliv 2008;5:77-84 (Pubitemid 351536312)
65. Kerc J, Srcic S, Kofler B. Alternative solvent-free preparation methods for felodipine surface solid dispersions,. Drug Dev Ind Pharm 1998;24:359-63 (Pubitemid 28204505)
66. Papadimitriou SA, Bikiaris D, Avgoustakis K. Microwave-induced enhancement of the dissolution rate of poorly water-soluble tibolone from poly (ethylene glycol) solid dispersions. J Appl Polym Sci 2008;108:1249-58 (Pubitemid 351413065)
67. Bergese P, Colombo I, Gervasoni D, et al. Microwave generated nanocomposites for making insoluble drugs soluble,. Mater Sci Eng 2003;23:791-5 (Pubitemid 37507276)
68. Moneghini M, Zingone G, De Zordi N. Influence of the microwave technology on the physical-chemical properties of solid dispersion with nimesulide. Powder Techn 2009;195:259-63
69. Moneghini M, Bellich B, Baxa P, et al. Microwave generated solid dispersions containing Ibuprofen. Int J Pharm 2008;361:125-30
70. Maurya D, Belgamwar V, Tekade A. Microwave induced solubility enhancement of poorly water soluble atorvastatin calcium. J Pharm Pharmacol 2010;62:1599-606
71. Moneghini M, De Zordi N, Solinas D, et al. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology. Future Med Chem 2010;2:237-46
72. Del Arco M, Fernandez A, Martin C, et al. Solubility and release of fenbufen intercalated in Mg, Al and Mg, Al, Fe layered double hydroxides (LDH): the effect of Eudragits S 100 covering. J Solid State Chem 2010;183:3002-9
73. Berber MR, Minagawa K, Katoh M, et al. Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enchancement. Eur J Pharm Sci 2008;35:354-60
74. Ambrogi V, Perioli L, Ciarnelli V, et al. Effect of gliclazide immobilization into layered double hydroxide on drug release. Eur J Pharm Biopharm 2009;73:285-91
75. Choi G, Lee JH, Oh YJ, et al. Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid. Int J Pharm 2010;402:117-22
76. Panda HS, Srivastava R, Bahadur D. In-vitro release kinetics and stability of anticardiovascular drugs-intercalated layered double hydroxide nanohybrids. J Phys Chem B 2009;113:15090-100
77. Zhang H, Zou K, Guo S, et al. Nanostructural drug-inorganic clay composites: Structure, thermal property and in vitro release of captopril-intercalated Mg-Al-layered double hydroxides. J Solid State Chem 2006;179:1792-801 (Pubitemid 43782577)
78. Berber MR, Hafez IH, Minagawa K, et al. Nanocomposite formulation system of lipid-regulating drugs based on layered double hydroxide: synthesis, characterization and drug release properties. Pharm Res 2010;27:2394-401
79. Friedrich H, Fussnegger B, Kolter K, et al. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur J Pharm Biopharm 2006;62:171-7 (Pubitemid 43143269)
80. Kortesuo P, Ahola M, Kangas M, et al. In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters. Int J Pharm 2001;221:107-14 (Pubitemid 32524040)
81. Finnie KS, Waller DJ, Perret FL, et al. Biodegradability of sol-gel silica microparticles for drug delivery. J Sol-Gel Sci Technol 2009;49:12-18
82. Takeuchi H, Nagira S, Yamamoto H, et al. Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Powder Techn 2004;141:187-95 (Pubitemid 38726136)
83. Pokharkar VB, Mandpe LP, Padamwar MN, et al. Development, characterization and stabilization of amorphous form of low Tg drug. Powder Tech 2006;167:20-5 (Pubitemid 44215984)
84. Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of dimvastatin, a low Tg drug: In vitro and in vivo evaluations. Pharm Res 2005;22:990-8 (Pubitemid 40898109)
85. Papadimitriou S, Bikiaris D. Dissolution rate enhancement of the poorly water-soluble drug tibolone using PVP, Si O2, and their nanocomposites as appropriate drug carriers. Drug Dev Ind Pharm 2009;35:1128-38
86. Tan A, Simovic S, Davey AK, et al. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J Control Release 2009;134:62-70
87. Slowing II, Vivero-Escoto JL, Wu CW, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008;60:1278-88
88. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;46:7548-58 (Pubitemid 47556998)
89. Wang S. Ordered mesoporous materials for drug delivery. Micropor Mesopor Mater 2009;117:1-9
90. Thomas MJK, Slipper I, Walunj A, et al. Inclusion of poorly soluble drugs in highly ordered mesoporous silica Nanoparticles. Int J Pharm 2010;387:272-7
91. Takeuchi H, Nagira H, Yamamoto H, et al. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int J Pharm 2005;293:155-64 (Pubitemid 40381089)
92. Zhang Y, Zhi Z, Jiang T, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release 2010;145:257-63
93. Uchino T, Yasuno N, Yanagihara Y, et al. Solid dispersion of spironolactone with porous silica prepared by the solvent method. Pharmazie 2007;62:599-63
94. Van Speybroeck M, Barillaro V, Thi TD, et al. Ordered mesoporous silica material SBA-15: A broad-spectrum formulation platform for poorly soluble Drugs. J Pharm Sci 2009;98:2648-58
95. Bikiaris D. Solid dispersions, Part I: recent evolutions & future opportunities in manufacturing methods for dissolution rate enhancement of poorly water soluble drugs. Expert Opin Drug Deliv Sep 2011. [Epub ahead of print]
96. Patterson JE, James MB, Forster AH, et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm 2007;336:22-34 (Pubitemid 46551551)